Guizhou Bailing Group Pharmaceutical Co., Ltd.

XSEC:002424 Stock Report

Market Cap: CN¥5.5b

Guizhou Bailing Group Pharmaceutical Balance Sheet Health

Financial Health criteria checks 3/6

Guizhou Bailing Group Pharmaceutical has a total shareholder equity of CN¥3.5B and total debt of CN¥1.8B, which brings its debt-to-equity ratio to 51.4%. Its total assets and total liabilities are CN¥7.2B and CN¥3.7B respectively.

Key information

51.4%

Debt to equity ratio

CN¥1.80b

Debt

Interest coverage ration/a
CashCN¥170.62m
EquityCN¥3.49b
Total liabilitiesCN¥3.66b
Total assetsCN¥7.15b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 002424's short term assets (CN¥3.9B) exceed its short term liabilities (CN¥3.4B).

Long Term Liabilities: 002424's short term assets (CN¥3.9B) exceed its long term liabilities (CN¥266.7M).


Debt to Equity History and Analysis

Debt Level: 002424's net debt to equity ratio (46.6%) is considered high.

Reducing Debt: 002424's debt to equity ratio has reduced from 54.7% to 51.4% over the past 5 years.

Debt Coverage: 002424's debt is not well covered by operating cash flow (8.8%).

Interest Coverage: Insufficient data to determine if 002424's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies